4th Quarter - Termination Amendment
W STRATEGIES, LLC for HORIZON PHARMA USA, INC.
Firm
Client
Income
$20,000
Expenses
—
Terminated
Dec 31, 2015
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Termination | Jan 20, 2016 | $20,000 | Replaced |
| 4th Quarter - Termination Amendment (this page) | Jan 20, 2016 | $20,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6: 21st Century Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
Monitored legislation efforts to reform the corporate tax system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Copyright/Patent/Trademark CPT
H.R. 9: Innovation Act, including proposed changes to the Inter Partes Review (IPR) process at the Patent and Trademark Office (PTO).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.